共 50 条
- [1] Pharmacokinetic interactions between cobicistat-boosted elvitegravir and darunavir in HIV-infected patientsJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (03) : 816 - 819Gutierrez-Valencia, AliciaBenmarzouk-Hidalgo, Omar J.Llaves, SilviaFernandez-Magdaleno, TamaraEspinosa, NuriaViciana, PompeyoLopez-Cortes, Luis F.
- [2] Cobicistat-Boosted Protease Inhibitors in HIV-Infected Patients with Mild to Moderate Renal ImpairmentHIV CLINICAL TRIALS, 2014, 15 (06): : 269 - 273McDonald, Cheryl K.Martorell, ClaudiaRamgopal, MotiLaplante, FrancoisFisher, MartinPost, Frank A.Liu, YapeiCurley, JoanneAbram, Michael E.Custodio, JosephGraham, HibaRhee, Martin S.Szwarcberg, Javier
- [3] Darunavir concentrations in CSF of HIV-infected individuals when boosted with cobicistat versus ritonavirJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (09) : 2574 - 2577Bartels, HanniDecosterd, LaurentBattegay, ManuelMarzolini, Catia
- [4] Darunavir/cobicistat maintains the effectiveness of darunavir/ritonavir in HIV-infected patients under mono or dual therapyHIV CLINICAL TRIALS, 2018, 19 (05): : 197 - 201Mena, AlvaroCid, PurificacionDuenas, CarlosAngeles Garcinuno, MariaFrancisco Lorenzo, JuanMargusino, LuisQuinones, MarinaGrande, CarmenRodriguez-Osorio, IriaCastro, Angeles
- [5] Observational study to evaluate discontinuation of monotherapy with cobicistat-boosted darunavir in patients with human immunodeficiency virusMEDICINE, 2022, 101 (49) : E32208Solana-Altabella, AntonioMonte-Boquet, EmilioMontero, MartaPerez-Huertas, PabloCuellar-Monreal, Maria JesusSalavert, MiguelPoveda-Andres, Jose Luis
- [6] Rilpivirine plus cobicistat-boosted darunavir as alternative to standard three-drug therapy in HIV-infected, virologically suppressed subjects: Final results of the PROBE 2 trialANTIVIRAL THERAPY, 2021, 26 (3-5) : 51 - 57Maggiolo, FrancoGianotti, NicolaComi, LauraDi Filippo, ElisaFumagalli, LauraNozza, SilviaGalli, LauraValenti, DanielaRizzi, MarcoCastagna, Antonella
- [7] Voriconazole and cobicistat-boosted antiretroviral salvage regimen co-administration to treat invasive aspergillosis in an HIV-infected patientJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (04) : 1125 - 1127Ambrosioni, JuanColl, SandraManzardo, ChristianNicolas, DavidAguero, FernandoLuis Blanco, JoseTuset, MontseBrunet, MerceGatell, Jose M.Miro, Jose M.
- [8] Pharmacokinetics of darunavir/cobicistat and etravirine alone and co-administered in HIV-infected patientsJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (03) : 732 - 737Molto, JoseCurran, AdrianMiranda, CristinaChallenger, ElizabethRamon Santos, JoseRibera, EstebanKhoo, SayeValle, MartaClotet, Bonaventura
- [9] NON-INFERIORITY OF ONCE-DAILY COBICISTAT-BOOSTED DARUNAVIR VERSUS RITONAVIR-BOOSTED DARUNAVIR IN HIV-1-INFECTED ADULT PATIENTS: AN ADJUSTED COMPARATIVE ANALYSIS OF POOLED PHASE 3 DATAVALUE IN HEALTH, 2014, 17 (07) : A664 - A664Van Sanden, S.Thilakarathne, P.Opsomer, M.Mrus, J.Vanveggel, S.Lathouwers, E.Adriaenssen, I
- [10] Darunavir minimum plasma concentration and ritonavir-boosted darunavir monotherapy outcome in HIV-infected patientsANTIVIRAL THERAPY, 2014, 19 (05) : 443 - 447Gutierrez-Valencia, AliciaTorres-Cornejo, AlmudenaBenMarzouk-Hidalgo, Omar J.Ruiz-Valderas, RosaLluch, AmparoViciana, PompeyoLopez-Cortes, Luis F.